Le Lézard
Classified in: Health, Science and technology
Subject: Award

Omkar Marathe, MD, of The Oncology Institute of Hope and Innovation Selected for 40 Under 40 in Cancer Award

The Oncology Institute of Hope and Innovation (TOI) is proud to announce that Omkar Marathe, MD, a TOI physician, has received the "40 Under 40 in Cancer" award.

The 40 Under 40 in Cancer award celebrates the contributions of emerging leaders in cancer care under the age of 40. The award's sponsors include the Association for Value-Based Cancer Care.

Dr. Marathe treats patients with cancer and blood disorders in the greater Long Beach Area and has received a teaching award for his work with the St. Mary's Internal Medicine residency program. He has conducted research and published papers in various disciplines of oncology including ocular melanoma and HER2+ breast cancer and was recently named Director for TOI's highly esteemed clinical trials program. Dr. Marathe is fluent in English, Spanish, Marathi, and conversational Hindi.

Brad Hively, TOI's CEO, commented: "All of us at The Oncology Institute are incredibly proud of our colleague Dr. Marathe for being selected for this award. He represents what's best about our company: a dedicated and talented clinician providing innovative and compassionate cancer care to our patients."

About The Oncology Institute of Hope and Innovation

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is one of the largest community oncology practices in the US as well as our nation's leading value-based oncology services platform. TOI employs 75 physicians and mid-level practitioners in 42 clinic locations, with more than 500 total employees helping to offer leading-edge, evidence-based cancer care to a population of more than 1.5 million patients. TOI brings comprehensive, integrated cancer care into community settings, including clinical trials, palliative care programs, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced tertiary care settings. For more information visit www.theoncologyinstitute.com.

These press releases may also interest you

at 11:13
Drug shortages remain a global challenge and COVID-19 has increased demand for certain drugs, adding to the complexity of ensuring drug supply where it is needed. The Government of Canada remains steadfast in its efforts to ensure Canadians have...

at 11:00
The most recent data on the evolution of COVID-19 in Québec show 1,480 new cases, bringing the total number of people infected to 139,643. The data also report 37 new deaths, for a total of 7 021. Among these 37 deaths, 10 have occurred in the last...

at 09:00
Sciton Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies, launches a new advertising series "You Deserve Better, You Deserve Sciton" to coincide with the holiday season....

27 nov 2020
The food recall warning issued on November 26, 2020 has been updated to include additional distribution information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Vegpro...

27 nov 2020
According to a new Arthritis Research Canada study, rheumatoid arthritis patients are turning to Reddit ? a popular social media platform ? to discuss their mental health. Researchers examined a total of 81 threads from two popular discussion boards...

27 nov 2020
UT Health San Antonio's Sam and Ann Barshop Institute for Longevity and Aging Studies announced Nov. 27 that enrollment is open for a new clinical trial called PREVENTABLE. The study will investigate whether taking atorvastatin, a drug commonly used...

News published on 21 october 2020 at 11:35 and distributed by: